Keith Publications Logo Keith Publications
  Cluster 3: Health, Medicine & Life Sciences

Open Access Journals for Drug Research (2026)

Drug research — from target identification and lead compound discovery through clinical trials and post-marketing surveillance — generates findings that need broad scientific scrutiny and rapid dissemination. Open access journals for drug research ensure that pharmacological discoveries, drug formulation innovations, and clinical pharmacology findings are freely accessible to pharmaceutical scientists, clinicians, and regulators worldwide. Keith Publications JPBR is the premier open access drug research journal in the portfolio.

Submit Your Manuscript Browse All Topics

What to Look for When Choosing a Journal

Before submitting your research, evaluate journals on these key criteria:

  • Fully open access — no reader subscription, paywall, or institutional barrier
  • Creative Commons CC BY 4.0 licence allowing broad sharing and reuse
  • Indexed in Google Scholar, CrossRef, and open access health directories
  • Wide dissemination to both academic and clinical health audiences
  • DOI (CrossRef) assignment for permanent, citable article identification
  • Affordable APC with waiver options for eligible researchers

Recommended Journals — Cluster 3: Health, Medicine & Life Sciences

All journals below are published by Keith Publications — open access, peer-reviewed, and indexed for global discoverability.

  • Health Sciences and Medical Research Journal (HSMRJ)

    Health sciences, clinical medicine, public health, epidemiology, biomedical research, and interdisciplinary studies advancing human health outcomes.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Health Sciences Clinical Medicine Public Health Epidemiology
    Submit Manuscript View Journal
  • Columbia Journal of Medicine and Healthcare (CJMH)

    Medical research, healthcare delivery, hospital management, clinical practice, health policy, and translational medicine bridging research and patient care.

    Review: 2–3 weeks Open Access DOI (CrossRef) Google Scholar
    Medical Research Healthcare Delivery Clinical Practice Health Policy
    Submit Manuscript View Journal
  • Journal of Nursing and Allied Health Sciences (JNAHS)

    Nursing practice, allied health professions, patient care, clinical nursing research, health education, and evidence-based practice across healthcare settings.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Nursing Practice Allied Health Patient Care Health Education
    Submit Manuscript View Journal
  • Journal of Pharmacology and Biomedical Research (JPBR)

    Pharmacology, drug discovery, biomedical sciences, life sciences, oncology, biochemistry, and molecular medicine with clinical and applied relevance.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Pharmacology Drug Research Biomedical Sciences Life Sciences
    Submit Manuscript View Journal

Fast Publication: All Keith Publications journals complete initial review within 2–5 business days and full peer review within 2–4 weeks. Articles are published online within 5–10 days of acceptance — making us one of the fastest open access publishers in the health sciences and medicine field.

Why Open Access Publishing Benefits Health Sciences Researchers

Open access publication is especially powerful for health sciences and medical research. Your clinical findings, pharmacological discoveries, nursing practice evidence, and public health data become freely accessible to clinicians, policymakers, healthcare managers, and researchers worldwide — not just those at institutions with expensive journal subscriptions. A rural nurse in Tanzania, a community pharmacist in Vietnam, or a public health officer in Guatemala can access and apply your research if it is published open access. Studies consistently show that open access health research articles receive significantly more downloads and citations than subscription-based equivalents.

Understanding the CC BY 4.0 Licence for Health Research

All Keith Publications journals publish under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. This means anyone — clinicians, researchers, health educators, pharmaceutical companies, or policymakers — can freely read, share, download, and adapt your research for any purpose, including commercial use, as long as they credit the original authors. This licence is endorsed by major research funders including Wellcome Trust, NIH, and research councils worldwide. It maximises the societal and clinical impact of your research and fully complies with open access mandates from health research funding bodies.

Tips to Maximise Your Acceptance Chances

  1. Align your topic with the journal's scope — read the aims and scope carefully before submitting.
  2. Write a compelling abstract — clearly state your research question, methodology, key findings, and clinical or scientific significance.
  3. Ensure ethical compliance — include ethics committee approval, patient consent, and clinical trial registration details where applicable.
  4. Follow reporting guidelines — use CONSORT, STROBE, CARE, PRISMA, or other relevant Equator Network standards for your study design.
  5. Use current and relevant references — cite recent publications alongside seminal works in your health sciences discipline.
  6. Follow formatting guidelines exactly — non-compliant manuscripts are often desk-rejected without peer review.
  7. State practical implications — explain how your health or medical findings can improve patient care or inform health policy.

Frequently Asked Questions

Which open access journals are best for drug research?
The Journal of Pharmacology and Biomedical Research (JPBR) from Keith Publications is the best open access journal for drug research — covering drug discovery, pharmacokinetics, clinical pharmacology, drug formulation, and toxicology, fully open access with CrossRef DOI and Google Scholar indexing.
Can pharmacokinetics and drug metabolism research be published open access?
Yes. Pharmacokinetic studies, bioavailability and bioequivalence research, drug metabolism enzyme studies, and drug-drug interaction pharmacokinetics are within scope for open access publication at Keith Publications JPBR.
Is clinical drug safety research accepted in open access drug journals?
Yes. Adverse drug reaction case reports and case series, pharmacovigilance studies, drug-induced liver injury research, and systematic reviews of drug safety evidence are within scope and actively welcomed at Keith Publications open access drug research journals.
Do open access drug research journals serve regulators and industry equally?
Yes. Open access drug research is valuable to regulatory agencies reviewing new drug applications, to pharmaceutical companies assessing competitive landscapes, and to academic researchers building on published pharmacological evidence. Free access amplifies the impact across all drug research stakeholders.

Related Research Guides

Explore other research journal guides in the Health, Medicine & Life Sciences cluster:

Ready to Publish Your Research?

Submit your health sciences, medical, nursing, or life sciences manuscript to Keith Publications today. Fast peer review, open access, and global indexing — get your work published within weeks.

Submit Your Manuscript Now Contact the Editorial Team